Mikael Von Euler
Senior Vice President and Chief Medical Officer
Pharmaceutical Sciences
Aprea Therapeutics
Sweden
Biography
Dr. von Euler is a medical oncologist with more than 25 years of experience in the pharmaceutical industry. Prior to joining Aprea Therapeutics, he was Chief Medical Officer at Oncos Therapeutics, where he continues to serve as a Medical Adviser. Dr. von Euler has also served as Cluster Head for the Her2 area (Herceptin, pertuzumab, T-DM1) at Roche/Genentech, Vice President of Oncology Europe at GlaxoSmithKline and Global Product Director of Arimidex/Nolvadex at AstraZeneca. Dr. von Euler received his MD and PhD degrees from the Karolinska Institute in Stockholm, Sweden.
Research Interest
Oncology, Pharmaceutical Sciences
